Cash Cash Equivalents - Abbvie Inc (NYSE:ABBV) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 162.35 USD -2.95%

Updated:

Abbvie Inc
Cash & Cash Equivalents

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Abbvie Inc
Cash & Cash Equivalents Peer Comparison

GILD

AMGN

MRNA

VRTX

REGN

Company		Cash & Cash Equivalents	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Abbvie Inc NYSE:ABBV	Cash & Cash Equivalents $12.8B	CAGR 3-Years 15%	CAGR 5-Years 12%	CAGR 10-Years 3%
	Gilead Sciences Inc NASDAQ:GILD	Cash & Cash Equivalents $8.4B	CAGR 3-Years 12%	CAGR 5-Years -14%	CAGR 10-Years 15%
	Amgen Inc NASDAQ:AMGN	Cash & Cash Equivalents $10.9B	CAGR 3-Years 20%	CAGR 5-Years 10%	CAGR 10-Years 11%
	Moderna Inc NASDAQ:MRNA	Cash & Cash Equivalents $2.9B	CAGR 3-Years 3%	CAGR 5-Years 35%	CAGR 10-Years N/A
	Vertex Pharmaceuticals Inc NASDAQ:VRTX	Cash & Cash Equivalents $11.2B	CAGR 3-Years 23%	CAGR 5-Years 33%	CAGR 10-Years 35%
	Regeneron Pharmaceuticals Inc NASDAQ:REGN	Cash & Cash Equivalents $16.2B	CAGR 3-Years 95%	CAGR 5-Years 62%	CAGR 10-Years 41%

See Also

Based on the financial report for Dec 31, 2023, Abbvie Inc's Cash & Cash Equivalents amounts to 12.8B USD.

Over the last year, the Cash & Cash Equivalents growth was 39%. The average annual Cash & Cash Equivalents growth rates for Abbvie Inc have been 15% over the past three years , 12% over the past five years , and 3% over the past ten years .

Join more than 131,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.